Brian Mangene
About Brian Mangene
Brian Mangene is the VP, WW Commercial and WW Brand Head for Deucravacitinib at Bristol Myers Squibb, with over 20 years of experience in pharmaceutical marketing and brand management.
Title
Brian Mangene currently holds the position of Vice President, Worldwide Commercial and Worldwide Brand Head for Deucravacitinib at Bristol Myers Squibb. In this role, he is responsible for leading the global commercial strategy for the product.
Company
Brian Mangene works at Bristol Myers Squibb, a global biopharmaceutical company. Based in New Jersey, USA, he plays a crucial role in overseeing the worldwide commercial initiatives for Deucravacitinib.
Background
Brian Mangene has over 20 years of experience in the pharmaceutical industry, specializing in marketing and brand management. His career began at Mobil Oil Corporation, where he worked as a Business Consultant from 1995 to 1999, focusing on business strategy and operations. He then moved into the pharmaceutical sector, holding significant roles at Bristol-Myers Squibb and Celgene.
Education and Expertise
Brian Mangene earned his MBA in Marketing from Cornell Johnson Graduate School of Management between 1999 and 2001. Prior to that, he completed his AB in Economics and Political Economy from Princeton University from 1990 to 1994. His educational background laid the foundation for his expertise in commercial strategy and brand management.
Achievements
During his tenure at Bristol-Myers Squibb, Brian Mangene played a key role in the commercial launch of Bydureon, a diabetes medication. At Celgene, he led global marketing efforts for rheumatology. Since joining Bristol Myers Squibb in 2014, he has been leading the global commercial strategy for Deucravacitinib.